• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

氯巴占与地西泮治疗焦虑症及停药的研究

A therapeutic and discontinuation study of clobazam and diazepam in anxiety neurosis.

作者信息

Lapierre Y D, Tremblay A, Gagnon A, Monpremier P, Berliss H, Oyewumi L K

出版信息

J Clin Psychiatry. 1982 Sep;43(9):372-4.

PMID:6126475
Abstract

The efficacy and safety of clobazam and diazepam were compared in 40 patients with generalized anxiety disorder in a 28 day non-placebo-controlled trial followed by a 3-day single-blind placebo washout. The two drugs were equally anxiolytic, and the anxiety symptoms of most patients were brought under control within 1 week. Both drugs were found to be nontoxic. Diazepam had slightly greater sedative properties than clobazam, which was the patients' preferred drug after 28 days of treatment. During placebo washout, anxiety returned to pretreatment levels. Abrupt withdrawal did not result in rebound phenomena.

摘要

在一项为期28天的非安慰剂对照试验中,对40例广泛性焦虑症患者比较了氯巴占和地西泮的疗效与安全性,随后进行了为期3天的单盲安慰剂洗脱期。两种药物的抗焦虑作用相当,大多数患者的焦虑症状在1周内得到控制。两种药物均无毒。地西泮的镇静作用略强于氯巴占,氯巴占是治疗28天后患者偏爱的药物。在安慰剂洗脱期,焦虑症状恢复到治疗前水平。突然停药未导致反跳现象。

相似文献

1
A therapeutic and discontinuation study of clobazam and diazepam in anxiety neurosis.氯巴占与地西泮治疗焦虑症及停药的研究
J Clin Psychiatry. 1982 Sep;43(9):372-4.
2
A placebo-controlled, double-blind comparison of clobazam and diazepam in the treatment of anxiety.氯巴占与地西泮治疗焦虑症的安慰剂对照双盲比较
J Clin Psychiatry. 1983 Aug;44(8):296-300.
3
Clobazam and diazepam in anxiety.氯巴占与地西泮治疗焦虑症
Clin Pharmacol Ther. 1981 Jul;30(1):95-100. doi: 10.1038/clpt.1981.132.
4
Effect of alprazolam and diazepam on anxiety and panic attacks in panic disorder: a controlled study.阿普唑仑和地西泮对惊恐障碍中焦虑和惊恐发作的影响:一项对照研究。
J Clin Psychiatry. 1986 Sep;47(9):458-60.
5
Double-blind comparison of ketazolam, diazepam and placebo in once-a-day vs t.i.d. dosing.
J Clin Psychiatry. 1980 Nov;41(11):386-92.
6
Anxiolytic efficacy and safety of ketazolam compared with diazepam and placebo.
Clin Ther. 1980;3(1):9-14.
7
Bromazepam and diazepam in generalized anxiety: a placebo-controlled study with measurement of drug plasma concentrations.溴西泮和地西泮治疗广泛性焦虑症:一项测量药物血浆浓度的安慰剂对照研究。
J Clin Psychopharmacol. 1983 Apr;3(2):80-7.
8
Multicenter double-blind efficacy and safety study comparing alprazolam, diazepam and placebo in clinically anxious patients.一项多中心双盲疗效与安全性研究,比较阿普唑仑、地西泮与安慰剂在临床焦虑症患者中的效果。
J Clin Psychiatry. 1981 Sep;42(9):347-51.
9
Alprazolam and diazepam in the treatment of generalized anxiety.阿普唑仑和地西泮治疗广泛性焦虑症
J Clin Psychopharmacol. 1984 Jun;4(3):125-9.
10
[Double-blind study of clobazam (Odipam) and diazepam in non-psychotic anxiety states].氯巴占(奥地泮)与地西泮治疗非精神病性焦虑状态的双盲研究
Med Pregl. 1989;42(1-2):19-21.

引用本文的文献

1
The Emerging Role of Metabotropic Glutamate Receptors in the Pathophysiology of Chronic Stress-Related Disorders.代谢型谷氨酸受体在慢性应激相关疾病病理生理学中的新作用
Curr Neuropharmacol. 2016;14(5):514-39. doi: 10.2174/1570159x13666150515234920.
2
Allosteric modulation of metabotropic glutamate receptors: structural insights and therapeutic potential.变构调节代谢型谷氨酸受体:结构见解与治疗潜力。
Neuropharmacology. 2011 Jan;60(1):66-81. doi: 10.1016/j.neuropharm.2010.07.007. Epub 2010 Jul 14.
3
A risk-benefit assessment of buspirone in the treatment of anxiety disorders.
丁螺环酮治疗焦虑症的风险效益评估。
Drug Saf. 1997 Feb;16(2):118-32. doi: 10.2165/00002018-199716020-00004.
4
Changes in "withdrawal symptoms" following discontinuation of low-dose diazepam.低剂量地西泮停药后“戒断症状”的变化。
Psychopharmacology (Berl). 1996 Jun;125(4):392-7. doi: 10.1007/BF02246023.
5
Controlled comparison of pharmacological and psychological treatment of generalized anxiety disorder in primary care.初级保健中广泛性焦虑症药物治疗与心理治疗的对照比较。
Br J Gen Pract. 1990 Jul;40(336):289-94.